<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40921434</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><PubDate><Year>2025</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Impact of Digital Therapeutics for the Management of Adult Patients With Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>e70428</StartPage><MedlinePgn>e70428</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70428</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/70428</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The growing approval and use of digital therapeutics (DTx) for managing chronic diseases, such as diabetes, has prompted questions about their effectiveness.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This systematic review and meta-analysis aimed to report the effectiveness of DTx interventions in the management of patients with type 1 diabetes, type 2 diabetes, and prediabetes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data sources, including Web of Science, MEDLINE, Embase, and the Cochrane Library, were searched from inception to July 30, 2023. We included randomized controlled trials assessing the effectiveness of DTx interventions in the health management of individuals with prediabetes and those diagnosed with type 1 diabetes and type 2 diabetes. Our primary outcomes were glycated hemoglobin (HbA<sub>1c</sub>) levels, fasting blood glucose (FBG) levels, BMI, and weight. Trials that met the eligibility criteria were scored for risk of bias using the Cochrane Risk of Bias Tool 2.0. A narrative synthesis and meta-analysis of included studies were also conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19 studies were included in the meta-analysis (n=3264). The DTx intervention produced a noteworthy reduction in HbA<sub>1c</sub> levels among individuals with diabetes (weighted mean difference [WMD] -0.54%, 95% CI -0.72 to -0.36), as well as decreases in FBG levels (WMD -0.56, 95% CI -0.76 to -0.37) and BMI (WMD -0.84, 95% CI -1.23 to -0.45). In addition, it contributed to the increases in low-density lipoprotein cholesterol (WMD -0.13, 95% CI -0.22 to -0.03) and triglyceride levels (WMD -0.18, 95% CI -0.34 to -0.02). Subgroup analyses revealed a beneficial impact of DTx on improving HbA<sub>1c</sub> levels in patients with type 2 diabetes mellitus (mean difference -0.66, 95% CI -0.92 to -0.41). However, this intervention did not elicit a comparable improvement in HbA<sub>1c</sub> levels for patients with type 1 diabetes mellitus (mean difference -0.45, 95% CI -0.89 to -0.00). DTx did not significantly affect weight reduction (WMD -1.07, 95% CI -2.33 to 0.20), systolic and diastolic blood pressure, total cholesterol levels, or high-density lipoprotein levels.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The DTx intervention holds promise for enhancing health management among individuals with diabetes, potentially attenuating HbA<sub>1c</sub> levels, FBG levels, and BMI, especially in individuals with type 2 diabetes.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">PROSPERO CRD42023473743; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023473743.</AbstractText><CopyrightInformation>&#xa9;Mengyu Li, Ying Chen, Xuehui Chen, Han Yao, Lili You. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 08.09.2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Mengyu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0005-6878-2584</Identifier><AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0002-5923-4568</Identifier><AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Xuehui</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0001-9379-1686</Identifier><AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Han</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7240-0917</Identifier><AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Lili</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5645-4349</Identifier><AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011236" MajorTopicYN="N">Prediabetic State</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adult</Keyword><Keyword MajorTopicYN="N">blood glucose</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">digital therapeutics</Keyword><Keyword MajorTopicYN="N">health management</Keyword><Keyword MajorTopicYN="N">mHealth</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mobile health</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>9</Day><Hour>0</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>9</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>19</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40921434</ArticleId><ArticleId IdType="pmc">PMC12455173</ArticleId><ArticleId IdType="doi">10.2196/70428</ArticleId><ArticleId IdType="pii">v27i1e70428</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ISO/TR 11147:2023 Health informatics &#x2014; personalized digital health &#x2014; digital therapeutics health software systems. International Organization for Standardization. 2023.  [2025-02-19].  
 https://www.iso.org/standard/83767.html
.</Citation></Reference><Reference><Citation>GBD 2021 Diabetes Collaborators  Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023 Jul 15;402(10397):203&#x2013;34. doi: 10.1016/S0140-6736(23)01301-6. 
 
S0140-6736(23)01301-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01301-6</ArticleId><ArticleId IdType="pmc">PMC10364581</ArticleId><ArticleId IdType="pubmed">37356446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JC, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. 
 
S0168-8227(21)00478-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.109119</ArticleId><ArticleId IdType="pmc">PMC11057359</ArticleId><ArticleId IdType="pubmed">34879977</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf5;es Corr&#xea;a Galendi J, Leite RG, Banzato LR, Nunes-Nogueira VD. Effectiveness of strategies for nutritional therapy for patients with type 2 diabetes and/or hypertension in primary care: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022 Apr 02;19(7):4243. doi: 10.3390/ijerph19074243. 
 
ijerph19074243</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19074243</ArticleId><ArticleId IdType="pmc">PMC8998242</ArticleId><ArticleId IdType="pubmed">35409925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Moran LJ, Harrison CL, Ukke GG, Sood S, Bennett CJ, Bahri Khomami M, Absetz P, Teede H, Lim S. Ethnic differences in response to lifestyle intervention for the prevention of type 2 diabetes in adults: a systematic review and meta-analysis. Obes Rev. 2022 Jan;23(1):e13340. doi: 10.1111/obr.13340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13340</ArticleId><ArticleId IdType="pubmed">34528393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan P, Yan K, Balijepalli C, Druyts E. Changing face of healthcare: digital therapeutics in the management of diabetes. Curr Med Res Opin. 2021 Dec 23;37(12):2089&#x2013;91. doi: 10.1080/03007995.2021.1976737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2021.1976737</ArticleId><ArticleId IdType="pubmed">34511002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sverdlov O, van Dam J, Hannesdottir K, Thornton-Wells T. Digital therapeutics: an integral component of digital innovation in drug development. Clin Pharmacol Ther. 2018 Jul 23;104(1):72&#x2013;80. doi: 10.1002/cpt.1036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1036</ArticleId><ArticleId IdType="pubmed">29377057</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandian GS, Jain A, Raza Q, Sahu KK. Digital health interventions (DHI) for the treatment of attention deficit hyperactivity disorder (ADHD) in children - a comparative review of literature among various treatment and DHI. Psychiatry Res. 2021 Mar;297:113742. doi: 10.1016/j.psychres.2021.113742.S0165-1781(21)00039-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2021.113742</ArticleId><ArticleId IdType="pubmed">33515870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet CC, Jasik CB, Diebold A, DuPuis A, Jendretzke B. Cost savings and reduced health care utilization associated with participation in a digital diabetes prevention program in an adult workforce population. J Health Econ Outcomes Res. 2020;7(2):139&#x2013;47. doi: 10.36469/jheor.2020.14529. 
 
jheor-7-2-14529</Citation><ArticleIdList><ArticleId IdType="doi">10.36469/jheor.2020.14529</ArticleId><ArticleId IdType="pmc">PMC7458495</ArticleId><ArticleId IdType="pubmed">32884964</ArticleId></ArticleIdList></Reference><Reference><Citation>Moschonis G, Siopis G, Jung J, Eweka E, Willems R, Kwasnicka D, Asare BY, Kodithuwakku V, Verhaeghe N, Vedanthan R, Annemans L, Oldenburg B, Manios Y. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Lancet Digit Health. 2023 Mar;5(3):e125&#x2013;43. doi: 10.1016/S2589-7500(22)00233-3. 
 
S2589-7500(22)00233-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00233-3</ArticleId><ArticleId IdType="pubmed">36828606</ArticleId></ArticleIdList></Reference><Reference><Citation>Davison NJ, Guthrie NL, Medland S, Lupinacci P, Nordyke RJ, Berman MA. Cost-effectiveness analysis of a prescription digital therapeutic in type&#xa0;2 diabetes. Adv Ther. 2024 Feb;41(2):806&#x2013;25. doi: 10.1007/s12325-023-02752-2. 
 
10.1007/s12325-023-02752-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-023-02752-2</ArticleId><ArticleId IdType="pmc">PMC10838832</ArticleId><ArticleId IdType="pubmed">38170435</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care. 2020 May;9(5):2207&#x2013;13. doi: 10.4103/jfmpc.jfmpc_105_20. 
 
JFMPC-9-2207</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_105_20</ArticleId><ArticleId IdType="pmc">PMC7380804</ArticleId><ArticleId IdType="pubmed">32754475</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med. 1998 Jul;15(7):539&#x2013;53. doi: 10.1002/(SICI)1096-9136(199807)15:7&lt;539::AID-DIA668&gt;3.0.CO;2-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9136(199807)15:7&lt;539::AID-DIA668&gt;3.0.CO;2-S</ArticleId><ArticleId IdType="pubmed">9686693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern&#xe1;n MA, Hopewell S, Hr&#xf3;bjartsson A, Junqueira DR, J&#xfc;ni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JP. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. 2011.  [2025-02-19].  
 https://handbook-5-1.cochrane.org/
</Citation></Reference><Reference><Citation>Lin L. Comparison of four heterogeneity measures for meta-analysis. J Eval Clin Pract. 2020 Feb 24;26(1):376&#x2013;84. doi: 10.1111/jep.13159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jep.13159</ArticleId><ArticleId IdType="pubmed">31234230</ArticleId></ArticleIdList></Reference><Reference><Citation>Melsen WG, Bootsma MC, Rovers MM, Bonten MJ. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014 Feb;20(2):123&#x2013;9. doi: 10.1111/1469-0691.12494. 
 
S1198-743X(14)60045-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12494</ArticleId><ArticleId IdType="pubmed">24320992</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergenstal RM, Johnson M, Passi R, Bhargava A, Young N, Kruger DF, Bashan E, Bisgaier SG, Isaman DJ, Hodish I. Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. Lancet. 2019 Mar 16;393(10176):1138&#x2013;48. doi: 10.1016/S0140-6736(19)30368-X. 
 
S0140-6736(19)30368-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30368-X</ArticleId><ArticleId IdType="pmc">PMC6715130</ArticleId><ArticleId IdType="pubmed">30808512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia J, Guthrie NL, Lupinacci P, Gubbi A, Denham D, Berman MA, Bonaca MP. Randomized, controlled trial of a digital behavioral therapeutic application to improve glycemic control in adults with type 2 diabetes. Diabetes Care. 2022 Dec 01;45(12):2976&#x2013;81. doi: 10.2337/dc22-1099. 
 
147620</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-1099</ArticleId><ArticleId IdType="pmc">PMC9862458</ArticleId><ArticleId IdType="pubmed">36181554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu WC, Lau KH, Huang R, Ghiloni S, Le H, Gilroy S, Abrahamson M, Moore J. Utilization of a cloud-based diabetes management program for insulin initiation and titration enables collaborative decision making between healthcare providers and patients. Diabetes Technol Ther. 2016 Feb;18(2):59&#x2013;67. doi: 10.1089/dia.2015.0160. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2015.0160</ArticleId><ArticleId IdType="pmc">PMC4753582</ArticleId><ArticleId IdType="pubmed">26645932</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn CC, Clough SS, Minor JM, Lender D, Okafor MC, Gruber-Baldini A. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008 Jun;10(3):160&#x2013;8. doi: 10.1089/dia.2008.0283.10.1089/dia.2008.0283</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2008.0283</ArticleId><ArticleId IdType="pubmed">18473689</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachmechi I, Salam S, Amini M, Khan R, Spitznogle A, Belen T. Frequent monitoring of blood glucose levels via a remote patient monitoring system helps improve glycemic control. Endocr Pract. 2023 Jun;29(6):441&#x2013;7. doi: 10.1016/j.eprac.2023.03.270.S1530-891X(23)00333-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2023.03.270</ArticleId><ArticleId IdType="pubmed">36965657</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson C, Ellis SL, Gutin RS, Gottlieb PA. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technol Ther. 2008 Oct;10(5):369&#x2013;75. doi: 10.1089/dia.2007.0303. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2007.0303</ArticleId><ArticleId IdType="pmc">PMC2979335</ArticleId><ArticleId IdType="pubmed">18715213</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone RA, Rao RH, Sevick MA, Cheng C, Hough LJ, Macpherson DS, Franko CM, Anglin RA, Obrosky DS, Derubertis FR. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care. 2010 Mar;33(3):478&#x2013;84. doi: 10.2337/dc09-1012. 
 
dc09-1012</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-1012</ArticleId><ArticleId IdType="pmc">PMC2827492</ArticleId><ArticleId IdType="pubmed">20009091</ArticleId></ArticleIdList></Reference><Reference><Citation>Benhamou PY, Franc S, Reznik Y, Thivolet C, Schaepelynck P, Renard E, Guerci B, Chaillous L, Lukas-Croisier C, Jeandidier N, Hanaire H, Borot S, Doron M, Jallon P, Xhaard I, Melki V, Meyer L, Delemer B, Guillouche M, Schoumacker-Ley L, Farret A, Raccah D, Lablanche S, Joubert M, Penfornis A, Charpentier G. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. Lancet Digit Health. 2019 May;1(1):e17&#x2013;25. doi: 10.1016/s2589-7500(19)30003-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2589-7500(19)30003-2</ArticleId><ArticleId IdType="pubmed">33323237</ArticleId></ArticleIdList></Reference><Reference><Citation>Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, Catargi B, Melki V, Chaillous L, Farret A, Bosson JL, Penfornis A. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study) Diabetes Care. 2011 Mar;34(3):533&#x2013;9. doi: 10.2337/dc10-1259. 
 
dc10-1259</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-1259</ArticleId><ArticleId IdType="pmc">PMC3041176</ArticleId><ArticleId IdType="pubmed">21266648</ArticleId></ArticleIdList></Reference><Reference><Citation>Franc S, Joubert M, Daoudi A, Fagour C, Benhamou P, Rodier M, Boucherie B, Benamo E, Schaepelynck P, Guerci B, Dardari D, Borot S, Penfornis A, D'Orsay G, Mari K, Reznik Y, Randazzo C, Charpentier G. Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: the TeleDiab-2 randomized controlled trial. Diabetes Obes Metab. 2019 Oct 03;21(10):2327&#x2013;32. doi: 10.1111/dom.13806. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13806</ArticleId><ArticleId IdType="pmc">PMC6771866</ArticleId><ArticleId IdType="pubmed">31173451</ArticleId></ArticleIdList></Reference><Reference><Citation>Franc S, Hanaire H, Benhamou PY, Schaepelynck P, Catargi B, Farret A, Fontaine P, Guerci B, Reznik Y, Jeandidier N, Penfornis A, Borot S, Chaillous L, Serusclat P, Kherbachi Y, d'Orsay G, Detournay B, Simon P, Charpentier G. DIABEO system combining a mobile app software with and without telemonitoring versus standard care: a randomized controlled trial in diabetes patients poorly controlled with a basal-bolus insulin regimen. Diabetes Technol Ther. 2020 Dec 01;22(12):904&#x2013;11. doi: 10.1089/dia.2020.0021. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2020.0021</ArticleId><ArticleId IdType="pmc">PMC7757616</ArticleId><ArticleId IdType="pubmed">32407148</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal P, Mukerji G, Desveaux L, Ivers NM, Bhattacharyya O, Hensel JM, Shaw J, Bouck Z, Jamieson T, Onabajo N, Cooper M, Marani H, Jeffs L, Bhatia RS. Mobile app for improved self-management of type 2 diabetes: multicenter pragmatic randomized controlled trial. JMIR Mhealth Uhealth. 2019 Jan 10;7(1):e10321. doi: 10.2196/10321. 
 
v7i1e10321</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10321</ArticleId><ArticleId IdType="pmc">PMC6329896</ArticleId><ArticleId IdType="pubmed">30632972</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretschneider MP, Kl&#xe1;sek J, Karbanov&#xe1; M, Timpel P, Herrmann S, Schwarz PE. Impact of a digital lifestyle intervention on diabetes self-management: a pilot study. Nutrients. 2022 Apr 26;14(9):1810. doi: 10.3390/nu14091810. 
 
nu14091810</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14091810</ArticleId><ArticleId IdType="pmc">PMC9100754</ArticleId><ArticleId IdType="pubmed">35565782</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Meng F, Guo Q, Bai T, Hong Y, Song F, Ma Y. Effectiveness of mHealth management with an implantable glucose sensor and a mobile application among Chinese adults with type 2 diabetes. J Telemed Telecare. 2021 Jun 21;29(8):632&#x2013;40. doi: 10.1177/1357633x211020261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1357633x211020261</ArticleId><ArticleId IdType="pubmed">34152238</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafar N, Huriyati E, Haryani. Setyawati A. Enhancing knowledge of diabetes self-management and quality of life in people with diabetes mellitus by using Guru Diabetes Apps-based health coaching. J Public Health Res. 2023 Jul 13;12(3):22799036231186338. doi: 10.1177/22799036231186338. 
 
10.1177_22799036231186338</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/22799036231186338</ArticleId><ArticleId IdType="pmc">PMC10350768</ArticleId><ArticleId IdType="pubmed">37465530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DY, Park J, Choi D, Ahn HY, Park SW, Park CY. The effectiveness, reproducibility, and durability of tailored mobile coaching on diabetes management in policyholders: a randomized, controlled, open-label study. Sci Rep. 2018 Feb 26;8(1):3642. doi: 10.1038/s41598-018-22034-0. 
 
10.1038/s41598-018-22034-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22034-0</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-22034-0</ArticleId><ArticleId IdType="pmc">PMC5827660</ArticleId><ArticleId IdType="pubmed">29483559</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SL, Ong KW, Johal J, Han CY, Yap QV, Chan YH, Zhang ZP, Chandra CC, Thiagarajah AG, Khoo CM. A smartphone app-based lifestyle change program for prediabetes (D'LITE study) in a multiethnic Asian population: a randomized controlled trial. Front Nutr. 2021;8:780567. doi: 10.3389/fnut.2021.780567. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.780567</ArticleId><ArticleId IdType="pmc">PMC8819073</ArticleId><ArticleId IdType="pubmed">35141265</ArticleId></ArticleIdList></Reference><Reference><Citation>Moravcov&#xe1; K, Karbanov&#xe1; M, Bretschneider MP, Sovov&#xe1; M, O&#x17e;ana J, Sovov&#xe1; E. Comparing digital therapeutic intervention with an intensive obesity management program: randomized controlled trial. Nutrients. 2022 May 10;14(10):2005. doi: 10.3390/nu14102005. 
 
nu14102005</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102005</ArticleId><ArticleId IdType="pmc">PMC9143861</ArticleId><ArticleId IdType="pubmed">35631145</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamungkas RA, Usman AM, Chamroonsawasdi K, Abdurrasyid A smartphone application of diabetes coaching intervention to prevent the onset of complications and to improve diabetes self-management: a randomized control trial. Diabetes Metab Syndr. 2022 Jul;16(7):102537. doi: 10.1016/j.dsx.2022.102537.S1871-4021(22)00151-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2022.102537</ArticleId><ArticleId IdType="pubmed">35724489</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia JC, Meraj H, Teoh SH, Waqas A, Ahmad M, Lap&#xe3;o LV, Pataky Z, Golay A. Telemedicine to deliver diabetes care in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ. 2021 Mar 01;99(3):209&#x2013;19B. doi: 10.2471/BLT.19.250068. 
 
BLT.19.250068</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.19.250068</ArticleId><ArticleId IdType="pmc">PMC7941107</ArticleId><ArticleId IdType="pubmed">33716343</ArticleId></ArticleIdList></Reference><Reference><Citation>Brands MR, Gouw SC, Beestrum M, Cronin RM, Fijnvandraat K, Badawy SM. Patient-centered digital health records and their effects on health outcomes: systematic review. J Med Internet Res. 2022 Dec 22;24(12):e43086. doi: 10.2196/43086. 
 
v24i12e43086</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/43086</ArticleId><ArticleId IdType="pmc">PMC9816956</ArticleId><ArticleId IdType="pubmed">36548034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray R, Indraratna P, Lovell N, Ooi SY. Digital health technology in the prevention of heart failure and coronary artery disease. Cardiovasc Digit Health J. 2022 Dec;3(6 Suppl):S9&#x2013;16. doi: 10.1016/j.cvdhj.2022.09.002. 
 
S2666-6936(22)00154-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2022.09.002</ArticleId><ArticleId IdType="pmc">PMC9795268</ArticleId><ArticleId IdType="pubmed">36589760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederman R, D'Alfonso S. The digital therapeutic alliance: prospects and considerations. JMIR Ment Health. 2021 Jul 20;8(7):e31385. doi: 10.2196/31385. 
 
v8i7e31385</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/31385</ArticleId><ArticleId IdType="pmc">PMC8335609</ArticleId><ArticleId IdType="pubmed">34283035</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan P, Mitragotri S, Zhao Z. Digital therapeutics in the clinic. Bioeng Transl Med. 2023 Jul;8(4):e10536. doi: 10.1002/btm2.10536. 
 
BTM210536</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/btm2.10536</ArticleId><ArticleId IdType="pmc">PMC10354777</ArticleId><ArticleId IdType="pubmed">37476062</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlot B, Dispersyn G, Husson Z, Chanavaz-Lacheray I, Dennis T, Greco-Vuilloud J, Foug&#xe8;re M, Potvin S, Cotty-Eslous M, Roman H, Marchand S. Pain reduction with an immersive digital therapeutic tool in women living with endometriosis-related pelvic pain: randomized controlled trial. J Med Internet Res. 2022 Sep 21;24(9):e39531. doi: 10.2196/39531. 
 
v24i9e39531</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/39531</ArticleId><ArticleId IdType="pmc">PMC9536521</ArticleId><ArticleId IdType="pubmed">36129733</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, Angjeli E, Wu HC, Gaier ED, Gomez S, Travers DA, Binenbaum G, Langer R, Hunter DG, Repka MX. Randomized controlled trial of a dichoptic digital therapeutic for amblyopia. Ophthalmology. 2022 Jan;129(1):77&#x2013;85. doi: 10.1016/j.ophtha.2021.09.001. 
 
S0161-6420(21)00682-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2021.09.001</ArticleId><ArticleId IdType="pubmed">34534556</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Min J, Khuri J, Xue H, Xie B, A Kaminsky L, J Cheskin L. Effectiveness of mobile health interventions on diabetes and obesity treatment and management: systematic review of systematic reviews. JMIR Mhealth Uhealth. 2020 Apr 28;8(4):e15400. doi: 10.2196/15400. 
 
v8i4e15400</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/15400</ArticleId><ArticleId IdType="pmc">PMC7218595</ArticleId><ArticleId IdType="pubmed">32343253</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberle C, Stichling S. Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review. J Med Internet Res. 2021 Feb 19;23(2):e23244. doi: 10.2196/23244. 
 
v23i2e23244</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/23244</ArticleId><ArticleId IdType="pmc">PMC7935656</ArticleId><ArticleId IdType="pubmed">33605889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xue H, Huang Y, Huang L, Zhang D. A systematic review of application and effectiveness of mHealth interventions for obesity and diabetes treatment and self-management. Adv Nutr. 2017 May;8(3):449&#x2013;62. doi: 10.3945/an.116.014100. 
 
S2161-8313(22)00676-7</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.116.014100</ArticleId><ArticleId IdType="pmc">PMC5421120</ArticleId><ArticleId IdType="pubmed">28507010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou C, Carter B, Hewitt J, Francisa T, Mayor S. Do mobile phone applications improve glycemic control (HbA1c) in the self-management of diabetes? A systematic review, meta-analysis, and GRADE of 14 randomized trials. Diabetes Care. 2016 Nov;39(11):2089&#x2013;95. doi: 10.2337/dc16-0346.39/11/2089</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-0346</ArticleId><ArticleId IdType="pubmed">27926892</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>